X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CELL TRANSPLANTATION

期刊標題檢索 CELL TRANSPLANT 最新評論: Hello teacher, may I ask how long it takes for you to accept revisions... (2024-05-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CELL TRANSPLANTATION]您好,您是該頁面的第 43289 位訪客。

期刊簡介
期刊名稱CELL TRANSPLANTATION CELL TRANSPLANTATION
LetPub Score
6.2
50 ratings
Rate

Reputation
7.2

Influence
5.4

Speed
7.1

期刊簡稱CELL TRANSPLANT
ISSN0963-6897
E-ISSN1555-3892
h-index90
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.000.7010.625
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Transplantation
Q215 / 54
Category: Medicine
Subcategory: Biomedical Engineering
Q2114 / 303
Category: Medicine
Subcategory: Cell Biology
Q3166 / 285

自引率 (2023-2024)3.10%自引率趨勢
掲載範囲
Cell Transplantation, The Regenerative Medicine Journal is an open access, peer reviewed journal that is published 12 times annually. Cell Transplantation is a multi-disciplinary forum for publication of articles on cell transplantation and its applications to human diseases. Articles focus on a myriad of topics including the physiological, medical, pre-clinical, tissue engineering, stem cell, and device-oriented aspects of the nervous, endocrine, cardiovascular, and endothelial systems, as well as genetically engineered cells. Cell Transplantation also reports on relevant technological advances, clinical studies, and regulatory considerations related to the implantation of cells into the body in order to provide complete coverage of the field.
官方網站https://www.cognizantcommunication.com/journal-titles/cell-transplantation
在線稿件提交https://mc.manuscriptcentral.com/cogcom-ct
開放訪問Yes
出版商SAGE Publications Inc.
主題領域生物
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年0
每年文章數104每年文章數趨勢
黃金OA百分比95.50%
OA Related Info
APC: Yes( USD2650; )
APC waiver:Check Notes
Other charges: No
Keywords: cell transplantation、tissue engineering
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL & TISSUE ENGINEERINGSCIEQ319/31
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ281/189
TRANSPLANTATIONSCIEQ210/31
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0963-6897%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【CELL TRANSPLANTATION】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    STEM CELLS AND DEVELOPMENTH-index: 100

    CiteScore: 7.80
    學科內最受檢索的期刊 頁面查看次數
    STEM CELLS AND DEVELOPMENT48341
  •  

    CELL TRANSPLANTATION CELL TRANSPLANTATION
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [CELL TRANSPLANTATION] 的評論撰寫評論
作者: accept1111


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-25 14:28:30 評論於
Hello teacher, may I ask how long it takes for you to accept revisions? I am feeling a bit anxious waiting for the revisions
(0) 讚! | accept1111

作者: lijian0926


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-24 19:57:51 評論於
Originally a journal in Zone 2, the impact factor has been fluctuating between 3-4 as the interest in stem cell research declines. It is a journal with a fast review process and moderate standards. Personally, I feel that the review comments are very professional, and by reading them, you can get an idea of whether the reviewers are likely to agree with or are very close to the direction you are taking. You can learn a lot during the revision process. If the content of your article is solid but lacks innovation, you can give it a try
(0) 讚! | lijian0926

作者: 神古巧芹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-06 10:37:05 評論於
When using UnionPay payment, encountered the same issue, may I ask how did you resolve it? Thank you
(0) 讚! | 神古巧芹

作者: 宗室才捷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-30 17:11:13 評論於
Review speed: 12.0 | Submission success rate: 5.0
Emphasized research direction: Tumor; Natural active drug
Experience sharing: Too slow, submitted on April 27th, still no news, no one responds to urge, garbage journal
(0) 讚! | 宗室才捷

作者: 宗室才捷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-30 10:24:49 評論於
Review speed: 24.0 | Submission acceptance rate: 25.0 
Prominent research direction: Oncology 
Experience sharing: My roommate submitted a paper, it took 13 months from submission to acceptance
(0) 讚! | 宗室才捷

作者: 宗室才捷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-21 18:51:45 評論於
Review Speed: 12.0 | Submission Hit Rate: 50.0
Emphasis on Research Direction: Tumor; Sharing of Experience with Natural Active Drugs: It's insanely slow...Submitted on April 27th, reviewed on May 9th, it's already been 4 and a half months. The manuscript interface for urging reviews doesn't reply, so I found the associate editor's personal email, and occasionally they reply to me. But the editorial department won't rush the reviewers, just very zen a couple more reviewers... Just waiting
(0) 讚! | 宗室才捷

作者: 白云锐思


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-22 19:30:44 評論於
Review speed: 12.0 | Submission hit rate: 50.0 Experience sharing: slow
(0) 讚! | 白云锐思

作者: 白云锐思


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-22 13:15:40 評論於
Review speed: 24.0 | Submission success rate: 50.0
Experience sharing: Be cautious when submitting your paper if you are eager to graduate, as the review process is unusually slow
(0) 讚! | 白云锐思

作者: 仲夏甜茜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-24 08:18:31 評論於
"P
(0) 讚! | 仲夏甜茜

作者: 我是涛哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-11 23:09:46 評論於
Recently, I was invited to help with reviewing a manuscript. I reviewed it very carefully and provided valuable feedback. It seemed to be a research topic for a graduate student, and I thought it was done quite well. There were some small requests for the author to supplement additional data, which I thought was a pity. However, the second reviewer gave a low rating and recommended reconsideration. I don't know how it will develop from here. Of course, as a reviewer, I am willing to support the author. After all, they have put in a lot of hard work!
(0) 讚! | 我是涛哥哥

作者: 书生振琪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-07 22:09:27 評論於
Why can't I pay the layout fee after accepting it? The link always says "The transaction could not be processed." Is there anyone who can help me with this?
(0) 讚! | 书生振琪

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:42:43 評論於
Choose the post-hoc test method based on the data results obtained
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:14:27 評論於
Statistics generally uses the p-value obtained from significance testing methods, with P
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 23:34:27 評論於
What kind of post hoc test should I use?
(0) 讚! | 龙鳞孝礼

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:31:59 評論於
Please translate the following paragraph into English and Japanese, and title them ":" and ":"
(0) 讚! | 平原文波

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 23:08:27 評論於
Today I received an email asking for payment of $2300. Does anyone know how to make the payment and what is the deadline?
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 22:19:34 評論於
It is gratifying to see this journal steadily rising. There are reasons for strictness, as long as it is not rejection, I am willing to wait
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 22:00:20 評論於
Research focus: Clinical research experience sharing: Submitted in May, revised multiple times, received a response this month, reviewers are satisfied, expected to be online next year
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 19:55:20 評論於
Reviewing is really slow, the review process is also very strict, receiving a lot of revision suggestions, but the revisions are very helpful, I think it's very useful for improving personal articles. It can only be said that it is more suitable for people who are confident in their own writing
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 19:42:01 評論於
The first review will take a while, so if you're in a rush, it's better not to submit. They also have strict requirements for articles, so it's best suited for experienced writers to submit
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 19:10:46 評論於
Reviewing takes 8-12 weeks, but it can be expedited. The second review is generally faster than the first review, taking around two to three weeks
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 15:27:58 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0
Experience sharing: Received an email this month accepting the submission, preparing to pay the APC which is not as expensive as rumored, now it is $2300
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 14:56:54 評論於
My supervisor said my article was written very well, but I was still nervous when I first submitted it for publication at the end of June. There were no major revisions, just one minor revision, and I just received an acceptance email. Although it was not a quick process, as long as the article is solid, I should still have confidence!
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 14:28:04 評論於
Submitted in May, received first review in July, second review in September, finally received a response in November. It's not a superficial journal, the revision suggestions were very detailed, and it took 4 revisions to pass. However, the overall improvement of the article is significant, and I am very satisfied with my own work. I hope to receive the email proof as soon as possible
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 09:37:45 評論於
Submitted once in 2019, got rejected. My article was not very well-written back then. I spent the past two years learning, analyzing, and rewriting. I submitted again in October and received revision comments this month. I am very happy that it was not rejected this time
(0) 讚! | 上清雨真

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [CELL TRANSPLANTATION] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*